Full Length Research Paper
References
|
Adewumi MT, Njoku CH, Saidu Y, Abubakar MK, Shehu RA, Bilbis LS (2007). Serum chromium, copper and manganese levels of diabetic subjects in Katsina, Nigeria. Asian J. Biochem. 2:284-288. |
|
|
Akhlaghi F, Bagheri SM, Rajabi O (2012). A comparative study of relationship between micronutrients and gestational diabetes. ISRN Obstetr. Gynecol. Article 2012:470419. |
|
|
Akiibinu MO, Adesiyan AA, Olalekan AO (2012). Micronutrients and markers of oxidative stress in symptomatic HIV positive /AIDS Nigerians: A call for adjuvant micronutrient therapy. The Institute of Integrative Omics Appl. Biotechnol. J. IIOABJ 3(2):7-11. |
|
|
Al-Juboori IA, Al-Rawi R, Al –Hakeim HK (2009). Estimation of serum copper, manganese, selenium and zinc in hypothyroidism patients. IUFS J. Biol. 68(2):121-126. |
|
|
Anetor JI, Arisibo OA, Adedapo KS, Akingbola TS, Olorunnisola OS, Adeniyi FA (2007). Increase plasma manganese, partially reduced ascorbate 1 and absence of mitochondrial oxidative stress in type 2 diabetes mellitus: Implications for the superoxide uncoupling protein 2 (UCP-2) pathway. Biological Trace element Res. 120:19-27. |
|
|
Arinola OG, Akiibinu MO (2005). Effect of HIV, urinary schistosomiasis or malaria on the levels of nutritionally essential trace elements in Nigerians. Eur. J. Scientific Res. 6(1):65-73. |
|
|
Arinola OG, Charles-Davies O (2008). Micronutrient levels in the plasma of Nigerian females with breast cancer. Afr. J. Biotechnol. 7(11):16–20. |
|
|
Aschner JL, Aschner M (2005). Nutritional aspects of manganese homeostatis. Mol. Aspects Med. 26:353-362. |
|
|
Babalola OO, Anetor JI, Adeniyi AA (2003). Assessment of Se status of healthy adults in South West Nigeria. ASSEST Series A 3(4):111–120. |
|
|
Bolton EC, Mildvan AS, Boeke JD (2002). Inhibition of reverse transcriptase in vivo by elevated manganese ion concentration. Mol. Cell 9:879-889. |
|
|
Chernecky CC, Berger BJ (1997). Laboratory tests and diagnostic procedure. 2nd edition. Philadelphia. Saunders. pp. 367–368. |
|
|
Colecraft E (2008). HIV/AIDS: Nutritional implications and impact on human development. Proc. Nutr. Soc. 67:109-113. |
|
|
Combs GF (2001). Selenium in global food system. Br. J. Nutr. 85:517-547. |
|
|
Flores CR, Puga MP, Wrobel K, Sevilla EG, Wrobel K (2011). Trace elements status in diabetes mellitus type 2: possible role of the interaction between molybdebum and copper in the progress of typical complications. Diabetes Res. Clin. Practice 91:333-341. |
|
|
Food and Nutrition Board FNB (2001). Dietary reference intake for Vitamin A, Vitamin K, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Institute of Medicine Washington DC. National Academic Press. pp 197–223. |
|
|
Hill PG (1985). The measurement of albumin in serum and plasma. Ann. Clin. Biochem. 22:565–578. |
|
|
Hummel M, Standl E, Schnell O (2007). Chromium in metabolic and cardiovascular disease. Hormone Metab. Res. 39:741-743. |
|
|
Institute of Medicine (2000). Chromium picolinate: Prototype monograph In: Dietary supplements a framework for evaluating safety. Washington DC, Institute of Medicine P B1- B80. |
|
|
Kaneko JJ (1999). Clinical biochemistry of animals. 4th Edition (ed J.J Kaneko), Academic press, Inc. New York 932 pp. |
|
|
Kangralka VA, Patil SD, Bandivadekar RM (2010). Oxidative stress and diabetes: a review. Int. J. Pharm. Appl. 1:38-45. |
|
|
Khalili H, Soudbakhsh A, Hajiabdolbaghi M, Dashti –Kharidaki S, Poorzare A, Saeedi AA, Sharififar R (2008). Nutritional Status and serum Zinc and selenium levels in Iranian HIV infected individuals. BMC Infect. Dis. 8:165-171. |
|
|
Kobla HV, Volpe SL (2000). Chromium, exercise and body composition and weight loss. Crit. Rev. Food Sci. Nutr. 40(4):291-308. |
|
|
Kohrle J, Jacob F, Contempre B, Dumont JE (2005). Selenium, the thyroid and the endocrine system. Endocrine Rev. 26(7):944-984. |
|
|
Kolawole SE (2008). An assessment of the plasma status of selenium, chromium and manganese in adult Nigerians in health and disease in Akwa Ibom and Cross River States of Nigeria. PhD Thesis University of Calabar.196 pp. |
|
|
McPherson RA, Pincus MR (2011). Laboratory methods. Henry's Clinical Diagnosis and Management Expert Consult - Online and Print. 22nd ed. Saunders. |
|
|
Mueller AS, Pallauf J (2006). Compendium of antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. J. Nutr. Biochem. 17:548-560. |
|
|
Quallar E, Jimenez FJ, Veer PV, Bode P, Riemersma RA, Gomez – Aracena J, Kark JD, Arab L, Kok FJ, Martin – Moreno JM (2005). EURAMIC – Heavy metals and myocardial infarction study group. Low toe nails chromium concentration and increased risk of nonfatal myocardial infarction. Am. J. Epidemiol. 162:157-164. |
|
|
Reddy KS, Katan MB (2004). Diet, nutrition and the prevention of hypertension and cardiovascular diseases. Public Health Nutrition 7(1A):167-186. |
|
|
Safaralizadeh R, Kardar GA, Pourpak Z, Moin M, Zare A, Teimourian S (2005). Serum concentration of selenium in healthy individuals living in Tehran. Nutrition J. 4:32-34. |
|
|
Sotiropoulous A, Papadodima SA, Papazafiropoulou AK, Ioannidis A, Kokkinari A, Apostolou Q, Spiliopoulou CA, Athanaselis S (2011). Serum selenium levels do not differ in type II diabetic subjects with and without coronary artery disease. BMC Research Notes 4:270-276. |
|
|
Stein SA, McNurian M, Philips BT, Messina C, Mynarcik D (2013). Chromium therapy for insulin resistance associated with HIV disease. J. AIDS Clin. Res. 4:239–245. |
|
|
Stephensen CB, Marquis GS, Douglas SD, Kruzich LA, Wilson CM (2007). Glutathione, gluthatione peroxidase and selenium status in HIV positive and HIV negative adolescents and young adults. The Am. J. Clin. Nutr. 85:173-181. |
|
|
Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, Farinaro E, Clark LC, Reid ME (2006). Effects of selenium supplementation on cardiovascular disease incidence and mortality: Secondary analyses in a randomized clinical trial. Am. J. Epidemiol. 163(8):694-699. |
|
|
Williams BB, Kwakye GF, Wegrzynowicz M, Li D, Ashner M, Erikson KM, Bowman AB (2010). Altered manganese homeostatis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system. Toxicol. Sci.117:169-179. |
|
|
Yang SJ, Hwang SY, Choi HY, Yoo HY, Seo JA, Kim SG, Kim NH, Balk SH, Choi DS, Choi KM (2011). Serum seloprotein P levels in patients with type 2 diabetes and pre-diabetes: Implications for insulin resistance, inflammation and Atherosclerosis. J. Clin. Endocrinol. Metab. 96(8):1325-1329. |
|
|
Zablocka SK, Grajeta H (2012). The role of manganese in etiopathogenesis and prevention of selected diseases. Postepy higieny i medycyny doswiadczainej 66:549-553. |
|
|
Zhao L, Cox AG, Ruzicka JA, Bhat AA, Zhang W, Taylor EW (2000). Molecular modeling and in vitro activity of an HIV – I encoded glutathione peroxidase. Proc. Nat. Acad. Sci. 97(12):6356-6361. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
